NeuroFrontiers
Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.
So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.
31-45 of 388
MS in Women: How Life Stages Shape Treatment Decisions
NeuroFrontiersMS in Women: How Life Stages Shape Treatment Decisions
Is Friedreich’s Ataxia Developmental or Degenerative?
NeuroFrontiersIs Friedreich’s Ataxia Developmental or Degenerative?
Arnulf Koeppen, MD
Unpacking the Genetics of Friedreich’s Ataxia
NeuroFrontiersUnpacking the Genetics of Friedreich’s Ataxia
Arnulf Koeppen, MD
Friedreich’s Ataxia: Impact of Frataxin Loss
NeuroFrontiersFriedreich’s Ataxia: Impact of Frataxin Loss
Arnulf Koeppen, MD
Next-Generation MS Care: The Promise of Cell-Based Therapeutics
NeuroFrontiersNext-Generation MS Care: The Promise of Cell-Based Therapeutics
Mark Freedman, HBSc, MSc, MD, CSPQ, FAAN, FRCPC
BCMA mRNA CAR-T Shows Durable Benefit in MG
NeuroFrontiersBCMA mRNA CAR-T Shows Durable Benefit in MG
- advertisement
SPOTLIGHT Registry Findings on Eculizumab and Ravulizumab in gMG
NeuroFrontiersSPOTLIGHT Registry Findings on Eculizumab and Ravulizumab in gMG
RAISE Subgroup Analysis: Zilucoplan Without Prior Rescue Therapy in gMG
NeuroFrontiersRAISE Subgroup Analysis: Zilucoplan Without Prior Rescue Therapy in gMG
Mark Freedman, HBSc, MSc, MD, CSPQ, FAAN, FRCPC
Omaveloxolone in Friedreich’s Ataxia: Early Real-World Signals
NeuroFrontiersOmaveloxolone in Friedreich’s Ataxia: Early Real-World Signals
FA hiPSCs in Translational Drug Development
NeuroFrontiersFA hiPSCs in Translational Drug Development
Applying the 2024 McDonald Criteria: Real-World Impacts on MS Diagnosis
NeuroFrontiersApplying the 2024 McDonald Criteria: Real-World Impacts on MS Diagnosis
Aaron Miller, MD
- advertisement
Proactive Pregnancy Planning and Reproductive Care in MS
NeuroFrontiersProactive Pregnancy Planning and Reproductive Care in MS
Riley Bove, MD, MMSc
Advancing Pediatric MS Care: Insights from AAN 2026
NeuroFrontiersAdvancing Pediatric MS Care: Insights from AAN 2026
Elizabeth Wilson, MD
Emerging Serum microRNAs as Early Signals in MS
NeuroFrontiersEmerging Serum microRNAs as Early Signals in MS
